Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Grover

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004C A Sargent, G J Grover, M J Antonaccio, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogsG J Grover, C S Parham, D B Whigan, et al.
Pharmacology|January 1, 1992
Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanismF C Clayton, T A Hess, M A Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalimG J Gross, D A Mei, P G Sleph, et al.
Journal of Cardiovascular Pharmacology|July 1, 1995
Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential durationG J Grover, A J D'Alonzo, C S Parham, et al.
The Annals of Thoracic Surgery|March 1, 1987
Effect of aortic stenosis on oxygen balance in partially ischemic myocardiumG J Grover, P M Scholz, J W Mackenzie, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.
The American Journal of Physiology|September 1, 1996
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideG J Grover, A J D'Alonzo, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerationsG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agentsC A Sargent, M A Smith, S Dzwonczyk, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004C A Sargent, G J Grover, M J Antonaccio, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogsG J Grover, C S Parham, D B Whigan, et al.
Pharmacology|January 1, 1992
Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanismF C Clayton, T A Hess, M A Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalimG J Gross, D A Mei, P G Sleph, et al.
Journal of Cardiovascular Pharmacology|July 1, 1995
Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential durationG J Grover, A J D'Alonzo, C S Parham, et al.
The Annals of Thoracic Surgery|March 1, 1987
Effect of aortic stenosis on oxygen balance in partially ischemic myocardiumG J Grover, P M Scholz, J W Mackenzie, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.
The American Journal of Physiology|September 1, 1996
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideG J Grover, A J D'Alonzo, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerationsG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agentsC A Sargent, M A Smith, S Dzwonczyk, et al.
Pageof 14